ISRCTN ISRCTN95538067
DOI https://doi.org/10.1186/ISRCTN95538067
Secondary identifying numbers CZF/1/40
Submission date
24/06/2008
Registration date
19/08/2008
Last edited
20/02/2015
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Respiratory
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English Summary

Not provided at time of registration

Contact information

Prof Aziz Sheikh
Scientific

Division of Community Health Sciences: GP Section
The University of Edinburgh
20 West Richmond Street
Edinburgh
EH8 9DX
United Kingdom

Phone +44 (0)131 6514151
Email aziz.sheikh@ed.ac.uk

Study information

Study designPragmatic cluster randomised controlled trial
Primary study designInterventional
Secondary study designCluster randomised trial
Study setting(s)GP practice
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleCluster randomised controlled trial of an educational intervention for healthcare professionals into the management of school-age children with hayfever
Study hypothesisThe primary aim of this study is to examine the effectiveness of standardised allergy training in promoting disease-specific quality of life of adolescents with hayfever. A one-day short course which focuses specifically on allergic rhinitis and asthma will be delivered to practice nurses in Lothian.

The objectives are:
1. To evaluate the effectiveness of standardised allergy training for health care professionals on adolescent (12 - 18 years) rhinitis-specific quality of life
2. To examine the impact of improving symptoms of hayfever on examination performance of adolescents
3. To assess the change in allergy practice and improvement in confidence, understanding and managing allergy symptoms of trained nurses or doctors
Ethics approval(s)Lothian Research Ethics Committee, September 2008, ref: 08/S1102/37
ConditionSeasonal allergic rhinitis (hayfever)
InterventionThe randomisation is at the level of the general practice, i.e. the practices are the clusters.

The health care professional intervention is a one-day short course entitled 'Essential Asthma and Allergic Rhinitis' and is run by the charity Education for Health.

The patient intervention is one consultation with a nurse or doctor (both intervention and control groups). In the intervention arm, the nurse or doctor will have attended the training day. In the control arm the nurse or doctor will not have attended the training day.

The control group will also receive usual care and a leaflet on hayfever management (Allergy UK factsheet). Once the trial is complete, control practice staff will be invited to attend the course.
Intervention typeOther
Primary outcome measureDifference in the validated Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) score between the intervention and control groups at baseline and 3 and 6 weeks post-intervention.
Secondary outcome measures1. Symptom scores, assessed using a visual analogue scale at 3 and 6 weeks post intervention
2. Overall assessment of seasonal allergic rhinitis symptoms compared with the previous season, assessed 6 weeks post intervention
3. Number of general practitioner and practice nurse consultations for hayfever; prescribed (from clinical records) and over-the-counter (from patients) medication data will be collected for cost-effectiveness comparison. Theses will be assessed at end of hayfever period (September 2009)
4. Examination performance, assessed at end of hayfever period (September 2009)
5. Assessment of change in clinical practice on completion of trial
Overall study start date01/08/2008
Overall study end date30/11/2009

Eligibility

Participant type(s)Patient
Age groupChild
Lower age limit12 Years
Upper age limit18 Years
SexBoth
Target number of participants264
Participant inclusion criteria1. Young people (both males and females) aged 12 - 18 years
2. Hayfever, defined by the presence of a documented clinician diagnosis in the patient's health record and any evidence of treatment used for allergic rhinitis
Participant exclusion criteria1. Unable to give consent
2. Taking part in any other clinical trials involving treatment for allergic rhinitis
Recruitment start date01/08/2008
Recruitment end date30/11/2009

Locations

Countries of recruitment

  • Scotland
  • United Kingdom

Study participating centre

Division of Community Health Sciences: GP Section
The University of Edinburgh
Edinburgh
EH8 9DX
United Kingdom

Sponsor information

Chief Scientist Office of the Scottish Executive Health Department (UK)
Government

St Andrews House
Edinburgh
ED1 3DG
United Kingdom

Email elaine.moir@scotland.gsi.gov.uk
Website http://www.sehd.scot.nhs.uk/cso
ROR logo "ROR" https://ror.org/01bw7zm61

Funders

Funder type

Charity

Chief Scientist Office of the Scottish Executive Health Department (UK) (ref: CZF/1/40)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol article protocol 05/08/2010 Yes No
Results article results 05/06/2014 Yes No